C. Arzilli

发表

Prognostic value of reverse remodelling criteria in heart failure with reduced or mid‐range ejection fraction

M. Emdin, J. Lupón, A. Bayés‐Genís, 2021, ESC heart failure.

Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction.

M. Emdin, C. Passino, A. Giannoni, 2019, International journal of cardiology.

NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure.

M. Emdin, C. Passino, A. Giannoni, 2018, International journal of cardiology.

N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure

M. Emdin, M. Senni, C. Passino, 2018, European journal of preventive cardiology.

Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis.

M. Emdin, N. Martini, C. Rapezzi, 2021, Journal of the American Heart Association.

Safety and efficacy of levosimendan in patients with cardiac amyloidosis.

M. Emdin, C. Rapezzi, A. Aimo, 2020, European journal of internal medicine.

Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey

G. Parati, C. Autore, M. Metra, 2022, European journal of heart failure.

Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis.

M. Emdin, L. Ghiadoni, D. Francisci, 2020, International journal of cardiology.

Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets

M. Emdin, C. Passino, D. Cardinale, 2020, Heart Failure Reviews.

Cardiovascular disease and COVID-19: les liaisons dangereuses

M. Emdin, J. Lupón, A. Bayés‐Genís, 2020, European journal of preventive cardiology.

Sex differences in transthyretin cardiac amyloidosis

M. Emdin, S. Maffei, A. Aimo, 2023, Heart failure reviews.

ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study.

C. Autore, I. Olivotto, R. Pavasini, 2023, European journal of internal medicine.

Disease features and management of cardiomyopathies in women

G. Vergaro, C. Arzilli, V. Castiglione, 2024, Heart failure reviews.

Safety and efficacy of levosimendan in patients with cardiac amyloidosis.

C. Passino, A. Aimo, G. Vergaro, 2024, International journal of cardiology.